Urgent Liver Transplantation for Acute Liver Failure in Pregnant Women: The Optimum Timing for Delivery.


Journal

Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144

Informations de publication

Date de publication:
01 01 2023
Historique:
pubmed: 1 9 2022
medline: 15 12 2022
entrez: 31 8 2022
Statut: ppublish

Résumé

The occurrence of acute liver failure (ALF) in pregnant women due to an etiology unrelated to pregnancy (pregALF) that leads to liver transplantation (LT) has rarely been reported. The objective was to report the outcome of pregnant women and fetus and propose a strategy for the timing of delivery and of LT in these patients. Five consecutive pregnant patients with ALF were admitted to our center between 1986 and 2018 and underwent an LT. A systematic review of case reports concerning patients with pregALF who underwent LT was extracted from the literature. Three with gestational ages (GA) at admission of 15, 22, and 31 weeks of gestation (WG) were transplanted after delivery (n = 1) or intrauterine demise (n = 2) and 2 with GA of 16 and 23 WG before delivery. One infant survived in each group. Among the 32 cases published previously, 11 (34%) had been transplanted after delivery (median GA:31 [28-33]); 10 of these 11 infants were alive at birth. The other 21 mothers were transplanted before delivery (GA:21 WG [18-22]). The median GA at delivery was 30 WG [27.75-37]. Twelve of 21 infants were alive at birth. One-year survival among the ALF patients in our series and in the literature was 100%. Overall, the perinatal survival rate was low (64.8%). In pregnant patients presenting with ALF not related to the pregnancy, the LT lifesaving procedure had an excellent outcome. Overall, 65% of the infants were alive at delivery with major mortality in those fetus <22 WG despite continued pregnancy.

Sections du résumé

BACKGROUND
The occurrence of acute liver failure (ALF) in pregnant women due to an etiology unrelated to pregnancy (pregALF) that leads to liver transplantation (LT) has rarely been reported. The objective was to report the outcome of pregnant women and fetus and propose a strategy for the timing of delivery and of LT in these patients.
METHODS
Five consecutive pregnant patients with ALF were admitted to our center between 1986 and 2018 and underwent an LT. A systematic review of case reports concerning patients with pregALF who underwent LT was extracted from the literature.
RESULTS
Three with gestational ages (GA) at admission of 15, 22, and 31 weeks of gestation (WG) were transplanted after delivery (n = 1) or intrauterine demise (n = 2) and 2 with GA of 16 and 23 WG before delivery. One infant survived in each group. Among the 32 cases published previously, 11 (34%) had been transplanted after delivery (median GA:31 [28-33]); 10 of these 11 infants were alive at birth. The other 21 mothers were transplanted before delivery (GA:21 WG [18-22]). The median GA at delivery was 30 WG [27.75-37]. Twelve of 21 infants were alive at birth. One-year survival among the ALF patients in our series and in the literature was 100%. Overall, the perinatal survival rate was low (64.8%).
CONCLUSIONS
In pregnant patients presenting with ALF not related to the pregnancy, the LT lifesaving procedure had an excellent outcome. Overall, 65% of the infants were alive at delivery with major mortality in those fetus <22 WG despite continued pregnancy.

Identifiants

pubmed: 36042543
doi: 10.1097/TP.0000000000004290
pii: 00007890-202301000-00023
doi:

Types de publication

Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

172-180

Informations de copyright

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare no funding or conflicts of interest.

Références

Ichai P, Samuel D. Etiology and prognosis of fulminant hepatitis in adults. Liver Transpl. 2008;14:S67–S79.
Naoum EE, Leffert LR, Chitilian HV, et al. Acute fatty liver of pregnancy: pathophysiology, anesthetic implications, and obstetrical management. Anesthesiology. 2019;130:446–461.
Fesenmeier MF, Coppage KH, Lambers DS, et al. Acute fatty liver of pregnancy in 3 tertiary care centers. Am J Obstet Gynecol. 2005;192:1416–1419.
Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol. 2004;103:981–991.
Aloizos S, Seretis C, Liakos N, et al. HELLP syndrome: understanding and management of a pregnancy-specific disease. J Obstet Gynaecol. 2013;33:331–337.
Nelson DB, Byrne JJ, Cunningham FG. Acute fatty liver of pregnancy. Obstet Gynecol. 2021;137:535–546.
Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A review. BMC Pregnancy Childbirth. 2009;9:8.
Casey LC, Fontana RJ, Aday A, et al.; Acute Liver Failure Study Group. Acute liver failure (ALF) in Pregnancy: how much is pregnancy related? Hepatology. 2020;72:1366–1377.
Bernuau J, Goudeau A, Poynard T, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology. 1986;6:648–651.
Bismuth H, Samuel D, Castaing D, et al. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg. 1995;222:109–119.
Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379:2162–2172.
European Association for the Study of the Liver. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol. 2017;66:1047–1081.
Anders M, Quiñonez E, Goldaracena N, et al. [Liver transplantation during pregnancy in a patient with acute liver failure]. Acta Gastroenterol Latinoam. 2010;40:268–270.
Bertuzzo VR, Ravaioli M, Morelli MC, et al. Pregnant woman saved with liver transplantation from acute liver failure due to hepatitis E virus. Transpl Int. 2014;27:e87–e89.
Bourliere M, Le Treut YP, Manelli JC, et al. Chlormezanone-induced fulminant hepatitis in a pregnant woman: successful delivery and liver transplantation. J Gastroenterol Hepatol. 1992;7:339–341.
Catnach SM, McCarthy M, Jauniaux E, et al. Liver transplantation during pregnancy complicated by cytomegalovirus infection. Transplantation. 1995;60:510–511.
Eguchi S, Yanaga K, Fujita F, et al. Living-related right lobe liver transplantation for a patient with fulminant hepatic failure during the second trimester of pregnancy: report of a case. Transplantation. 2002;73:1970–1971.
Fair J, Klein AS, Feng T, et al. Intrapartum orthotopic liver transplantation with successful outcome of pregnancy. Transplantation. 1990;50:534–535.
Finlay DE, Foshager MC, Longley DG, et al. Ischemic injury to the fetus after maternal liver transplantation. J Ultrasound Med. 1994;13:145–148.
Greenberg M, Daugherty TJ, Elihu A, et al. Acute liver failure at 26 weeks’ gestation in a patient with sickle cell disease. Liver Transpl. 2009;15:1236–1241.
Hamilton MI, Alcock R, Magos AL, et al. Liver transplantation during pregnancy. Transplant Proc. 1993;25:2967–2968.
Horikoshi Y, Itoh H, Kikuchi S, et al. Successful living donor liver transplantation for fulminant hepatic failure that manifested immediately after cesarean delivery. Asaio J. 2012;58:174–176.
Jarufe N, Soza A, Pérez-Ayuso RM, et al. Successful liver transplantation and delivery in a woman with fulminant hepatic failure occurring during the second trimester of pregnancy. Liver Int. 2006;26:494–497.
Kanogawa N, Kanda T, Ohtsuka M, et al. Acute liver failure occurring during the first trimester of pregnancy successfully treated with living donor liver transplantation. Case Rep Transplant. 2013;2013:309545.
Kimmich N, Dutkowski P, Krähenmann F, et al. Liver transplantation during pregnancy for acute liver failure due to HBV infection: a case report. Case Rep Obstet Gynecol. 2013;2013:356560.
Laifer SA, Abu-Elmagd K, Fung JJ. Hepatic transplantation during pregnancy and the puerperium. J Matern Fetal Med. 1997;6:40–44.
Lo CM, Gertsch P, Fan ST. Living unrelated liver transplantation between spouses for fulminant hepatic failure. Br J Surg. 1995;82:1037.
Maddukuri VC, Stephenson CD, Eskind L, et al. Liver transplantation for acute liver failure at 11-week gestation with successful maternal and fetal outcome. Case Rep Transplant. 2012;2012:484080.
Mendizabal M, Rowe C, Piñero F, et al. Successful orthotopic liver transplantation and delayed delivery of a healthy newborn in a woman with fulminant hepatic failure during the second trimester of pregnancy. Ann Hepatol. 2014;13:288–292.
Merritt WT, Dickstein R, Beattie C, et al. Liver transplantation during pregnancy: anesthesia for two procedures in the same patient with successful outcome of pregnancy. Transplant Proc. 1991;23:1996–1997.
Moreno EG, García GI, Gómez SR, et al. Fulminant hepatic failure during pregnancy successfully treated by orthotopic liver transplantation. Transplantation. 1991;52:923–926.
Paternoster DM, Gerace PF, Manganelli F, et al. Acute hepatic failure in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2004;112:230–232.
Sequeira E, Wanyonyi S, Dodia R. Severe propylthiouracil-induced hepatotoxicity in pregnancy managed successfully by liver transplantation: A case report. J Med Case Rep. 2011;5:461.
Shanley CJ, Braun DK, Brown K, et al. Fulminant hepatic failure secondary to herpes simplex virus hepatitis. Successful outcome after orthotopic liver transplantation. Transplantation. 1995;59:145–149.
Simsek Y, Isik B, Karaer A, et al. Fulminant hepatitis A infection in second trimester of pregnancy requiring living-donor liver transplantation. J Obstet Gynaecol Res. 2012;38:745–748.
Thornton SL, Minns AB. Unintentional chronic acetaminophen poisoning during pregnancy resulting in liver transplantation. J Med Toxicol. 2012;8:176–178.
Thurman RH, König K, Watkins A, et al. Fulminant herpes simplex virus hepatic failure in pregnancy requiring liver transplantation. Aust N Z J Obstet Gynaecol. 2010;50:492–494.
Kato T, Nery JR, Morcos JJ, et al. Successful living related liver transplantation in an adult with fulminant hepatic failure. Transplantation. 1997;64:415–417.
Toti L, Manzia TM, Romano P, et al. Successful management of a same-day emergency delivery and liver transplant in a 27 weeks pregnant woman with fulminant hepatic failure. Transpl Int. 2010;23:114–115.
Valentine JM, Parkin G, Pollard SG, et al. Combined orthotopic liver transplantation and caesarean section for the Budd-Chiari syndrome. Br J Anaesth. 1995;75:105–108.
Vernadakis S, Fouzas I, Kykalos S, et al. Successful salvage delivery and liver transplantation for fulminant hepatic failure in a 34-week pregnant woman: a case report. Transplant Proc. 2012;44:2768–2769.
Zaballos J, Perez-Cerda F, Riaño D, et al. Anesthetic management of liver transplantation in a pregnant patient with fulminant hepatitis. Transplant Proc. 1991;23:1994–1995.
Lee JC, Li PH, Mok TY, et al. Acute exacerbation of hepatitis B with hepatic failure during the first trimester of pregnancy: delivery of a healthy term baby after liver transplantation. Hepatol Res. 2020;50:1386–1390.
Halliday J, Lokan J, Angus PW, et al. A case of fulminant hepatic failure in pregnancy. Hepatology. 2010;51:341–342.
Ancel PY, Goffinet F, Kuhn P, et al.; EPIPAGE-2 Writing Group. Survival and morbidity of preterm children born at 22 through 34 weeks’ gestation in France in 2011: results of the EPIPAGE-2 cohort study. JAMA Pediatr. 2015;169:230–238.
Ancel PY, Goffinet F; EPIPAGE 2 Writing Group. EPIPAGE 2: a preterm birth cohort in France in 2011. BMC Pediatr. 2014;14:97.
Pierrat V, Marchand-Martin L, Arnaud C, et al. Neurodevelopmental outcome at 2 years for preterm children born at 22 to 34 weeks’ gestation in France in 2011: EPIPAGE-2 cohort study. BMJ. 2017;358:j3448.
Azoulay D, Samuel D, Ichai P, et al. Auxiliary partial orthotopic versus standard orthotopic whole liver transplantation for acute liver failure: a reappraisal from a single center by a case-control study. Ann Surg. 2001;234:723–731.

Auteurs

Philippe Ichai (P)

Liver Intensive Care Unit, AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire, Villejuif, France.
INSERM Unité 1193, Université Paris-Saclay, Villejuif, France.
Departement Hospitalo-Universitaire, Hepatinov, Villejuif, France.

Hanane Bouchghoul (H)

Department of Obstetrics and Gynecology, AP-HP Hôpital Bicêtre, Le Kremlin-Bicêtre, France. Université Paris-Saclay.

Astrid Laurent-Bellue (A)

Department of Pathology, AP-HP Hôpital Bicêtre, Le Kremlin-Bicêtre, France.

Sophie-Caroline Sacleux (SC)

Liver Intensive Care Unit, AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire, Villejuif, France.
Departement Hospitalo-Universitaire, Hepatinov, Villejuif, France.

Marc Boudon (M)

Liver Intensive Care Unit, AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire, Villejuif, France.
INSERM Unité 1193, Université Paris-Saclay, Villejuif, France.
Departement Hospitalo-Universitaire, Hepatinov, Villejuif, France.

Daniel Cherqui (D)

INSERM Unité 1193, Université Paris-Saclay, Villejuif, France.
Departement Hospitalo-Universitaire, Hepatinov, Villejuif, France.
Department of Hepatobiliary Surgery, AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire, Villejuif, France.

Pauline Tortajada (P)

Department of Hepatobiliary Surgery, AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire, Villejuif, France.

Marius Braun (M)

Department of Hepatology, Rabin Medical Center, Liver Diseases Institute, Petah Tikva, IL.

Elise Lemaitre (E)

Liver Intensive Care Unit, AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire, Villejuif, France.

Gabriella Pittau (G)

INSERM Unité 1193, Université Paris-Saclay, Villejuif, France.
Departement Hospitalo-Universitaire, Hepatinov, Villejuif, France.
Department of Hepatobiliary Surgery, AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire, Villejuif, France.

Marie-Amélie Ordan (MA)

Liver Intensive Care Unit, AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire, Villejuif, France.
Departement Hospitalo-Universitaire, Hepatinov, Villejuif, France.

Sharon Levi (S)

Liver Intensive Care Unit, AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire, Villejuif, France.

Daniel Azoulay (D)

INSERM Unité 1193, Université Paris-Saclay, Villejuif, France.
Departement Hospitalo-Universitaire, Hepatinov, Villejuif, France.
Department of Hepatobiliary Surgery, AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire, Villejuif, France.

Herve Fernandez (H)

Department of Obstetrics and Gynecology, AP-HP Hôpital Bicêtre, Le Kremlin-Bicêtre, France. Université Paris-Saclay.

Catherine Guettier (C)

INSERM Unité 1193, Université Paris-Saclay, Villejuif, France.
Departement Hospitalo-Universitaire, Hepatinov, Villejuif, France.
Department of Pathology, AP-HP Hôpital Bicêtre, Le Kremlin-Bicêtre, France.

Didier Samuel (D)

Liver Intensive Care Unit, AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire, Villejuif, France.
INSERM Unité 1193, Université Paris-Saclay, Villejuif, France.
Departement Hospitalo-Universitaire, Hepatinov, Villejuif, France.

Faouzi Saliba (F)

Liver Intensive Care Unit, AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire, Villejuif, France.
INSERM Unité 1193, Université Paris-Saclay, Villejuif, France.
Departement Hospitalo-Universitaire, Hepatinov, Villejuif, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH